亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

聯苯芐唑原料藥廠家

 
 
單價 2.00 / 公斤對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 580公斤起訂1公斤
品牌 佳靈
型號 原料
規格 醫藥級
過期 長期有效
更新 2013-07-14 09:42
 

湖北佳靈醫藥化工有限公司

企業會員第15年
資料未認證
保證金未繳納
詳細說明

聯苯芐唑

15972030797----------------15972030797--------------15972030797--------------15972030797-----------------------15972030797-----------------------15972030797-------------------15972030797

中文同義詞:聯苯芐唑;1-[(1,1’-雙苯基)-4-基苯基甲基]-1-H-咪唑;白呋唑;1-(alpha-聯苯-4-基芐基)-1H-咪唑;4-[(RS)聯苯-4-基苯甲基]-咪唑三氟乙酸酯;1-[Α-(4-聯苯)芐基]-1H-咪唑;聯苯芐唑;1-[(1,1'-聯苯)-4-基苯基甲基]-1H-咪唑

英文名稱:Bifonazole

外觀   白色或類白色粉末

熔點   141~142.0.0℃

比旋光度   +102°

干燥失重 ≤0.1%

砷 ≤0.1mg/kg

重金屬 ≤2mg/kg

含量   ≥99.5%

包裝:25kg/紙板桶

用途   咪唑類外用抗真菌新藥,用于治療各種皮膚癬菌病,如體癬、股癬、手足癬等。

舉報收藏 0評論 0
更多>本企業其它產品
2-乙基-4-甲基咪唑原料廠家 倍他米松,倍他米松原料藥廠家 醋酸地塞米松,醋酸地塞米松原料藥廠家 達泊西汀,達泊西汀原料藥廠家 二丙酸倍他米松原料藥廠家 氟康唑原料藥廠家 甲苯咪唑原料藥廠家
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |